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Human metabolic diseases can be mimicked in rodents by using dietary interventions such as high fat
diets (HFD). Nonalcoholic fatty liver disease (NAFLD) develops as a result of HFD and the disease may
progress in a manner involving increased production of oxidants. The main intracellular source of these
oxidants are mitochondria, which are also responsible for lipid metabolism and thus widely recognized
as important players in the pathology and progression of steatosis. Here, we review publications that
study redox and bioenergetic effects of HFD in the liver. We ﬁnd that dietary composition and protocol
implementations vary widely, as do the results of these dietary interventions. Overall, all HFD promote
steatosis, changes in β-oxidation, generation and consequences of oxidants, while effects on body weight,
insulin signaling and other bioenergetic parameters are more variable with the experimental models
adopted. Our review provides a broad analysis of the bioenergetic and redox changes promoted by HFD
as well as suggestions for changes and speciﬁcations in methodologies that may help explain apparent
disparities in the current literature.
& 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Human metabolic diseases such as obesity, nonalcoholic stea-
tohepatitis (NASH), and the metabolic syndrome can be mimicked
in rodents by using genetic and dietary interventions. Both stra-
tegies lead to body weight gain, hyperglycemia, hyperinsulinemia,
hepatic steatosis and cardiac impairment [11,32,55]. Dietary
models are considered more similar to human metabolic diseases,
but there is no standard composition and duration for these diets
currently: High fat diets (HFD) range from 30% to 60% energy
content in fat, include saturated (SFA), monounsaturated (MUFA)
and polyunsaturated fatty acids (PUFA) and last from a few days
(short term) to over one week (long term) [11,36]. As a result, very
variable phenotypes are found in studies in the area, and data are
often difﬁcult to compare [11]. For example, the consumption of
different types of lipids has a variable effect on the energy ex-
penditure of mammals. Diets rich in SFAs lead to decreased basalB.V. This is an open access article u
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to diets containing predominantly unsaturated fatty acids
[41,54,68]. Furthermore, insulin resistance, an important step in
the development of the metabolic syndrome, can be inﬂuenced by
the lipid content of the diet, occurs more frequently in SFA and
MUFA-rich diets and may be minimized by the consumption of
PUFAs [10,30,44].
The nutrient overload generated by HFD in experimental ani-
mals resembles conditions of overnutrition and physical inactivity
that are major risk factors for the development of metabolic syn-
drome in humans [32,37]. These conditions, when combined, are
able to exceed the adipose tissue’s ability to handle excessive
energy, resulting in an increased efﬂux of non-esteriﬁed fatty acids
(NEFAs) and release of proinﬂammatory cytokines and adipokines
that may result in ectopic fat deposition in the liver, muscle and
heart [18,74].
In the liver, fat accumulation can be toxic [64,65]. Nonalcoholic
fatty liver disease (NAFLD) comprises several liver anomalies re-
lated to the accumulation of fat in hepatocytes, including simple
steatosis, a benign condition that may progress to serious liver
cirrhosis [12,6,65,69]. Currently, the accepted pathophysiological
model for NAFLD is the “two hits” model. First, there is accumu-
lation of triacylglycerides (TAG) and free fatty acids (FFA) in the
liver as a result of changes in the inﬂux, synthesis, oxidation and
transport of fatty acids. The second hit, triggered by the ﬁrst hit,
includes oxidative imbalance, decreased hepatic ATP production,
insulin resistance and induction of proinﬂammatory cytokines as ander the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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4.76%C57BL/6NTac
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Fig. 1. : Rat and mouse strain distribution in HFD studies.
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vation of inﬂammatory pathways as NF-kB and JNK [61,69].
The progression from simple steatosis to NASH involves increased
production of reactive oxygen and nitrogen species, lipotoxicity and
pro-inﬂammatory cytokines [7]. The main cellular source of these
oxidants is the mitochondrion [37,61], an organelle also responsible
for the lipid metabolism, which, consequently, plays an important
role in the pathology and progression of steatosis [29,61,6,66].
However, the parameters that characterize what is described as
“mitochondrial dysfunction”, including changes in oxygen con-
sumption, respiratory complex activity, oxidation of fatty acids and
mitochondrial DNA content, differ widely in the literature. In addition
to differences between genetic rodent strains of and human poly-
morphisms, part of the differences observed are probably due to the
type and duration of the diet [7].
Given the growing obesity epidemic [53] and the importance of
overnutrition in the development of diseases such as the meta-
bolic syndrome and NAFLD [18,37,69], we sought to evaluate and
to summarize changes in liver mitochondria related to the con-
sumption of HFD. We collected and discuss papers published over
the last 15 years that discussed metabolic changes in the livers of
rodents under HFD, focusing on dietary differences and mi-
tochondrial function.12. Rodents
Although there are some known metabolic differences between
rodents and humans, most laboratory metabolic disease studies
are conducted in rats or mice because of their inexpensive main-
tenance, small body size, relatively short lifespan, sequenced
genome, and superior physiological characterization compared to
other species such as pigs or dogs [2,71]. Studies selected in this
review were conducted in rodents, comprising mainly male ani-
mals and predominantly C57BL/6 mice (Table 1 and Fig. 1). Reuter
[59] deﬁned male C57BL/6J mice as the gold standard for a diet-
induced obesity (DIO), and we indeed ﬁnd it to be the strain used
in most papers. These animals are known to develop obesity only
under HFD, and metabolic parameters such as glucose intolerance
and insulin resistance are worsened over the exposure time to
these diets, as is seen in humans [43,59]. A point of notice that
should be considered when analyzing data in mice is that the
C57BL/6J mice from the Jackson Laboratories, but not C57BL/62
Table 1
Rodent studies using HFD: sex proﬁles.
Mice (n¼31) Rats (n¼15)
Male 24 14
Female 6 0
Both 1 1from the National Institute of Health, Taconic Labs or Charles River,
carry a spontaneous mutation in the nicotinamide nucleotide
transhydrogenase gene that has been implicated in several redox
alterations that can affect mitochondrial function [23,62]. C57BL/
6N mice do not harbor this mutation.
Mice and rats generally are started on the HFD at similar ages,
and were kept on the diet during widely variable times (Fig. 2).
Most of the papers analyzed used paired age groups. Ciapaite et al.,
2011, described increased body weights and fasting plasmatic
glucose and insulin levels as well as decreased oxidative phos-
phorylation capacity in 39-week-old animals fed with standard
chow diet (9.2% kcal from fat, vegetable oils) in comparison to
16.5-week-old Wistar rats. In addition, Fontana et al. [25], ob-
served that C57BL/6 aged animals (44 and 88 weeks old, fed
during 16 weeks with a HFD) did not show increased steatosis
compared to their younger counterparts, but exhibited increased
inﬂammation and hepatocellular injury that could contribute to
chronic liver disease development and progression. Thus, HFD
groups should be paired by diet and also by age to avoid mis-
interpretation of data.3. Diets and metabolic proﬁles
One important critique in HFD treatment is the difﬁculty to
compare studies because of their variability. There are some up-
dated reviews that compare metabolic ﬁndings between papers in
order to identify the causes of variation and why there is an in-
ability to unify the ﬁndings [11,32,43,7]. In this review, we focused
only on high energy diets containing fat as the main caloric source.
The papers analyzed present a myriad of experimental designs of
HFD interventions and signiﬁcant variation in measured para-
meters. Diet composition description from controls and high fat
groups is often overlooked by the authors and not fully provided in
the papers. Due to the lack of information in some papers, a few
assumptions were made to facilitate comparisons:
) Most authors refer to fat content as percentage of energy from
fat, since ad libitum feeding will be determined by energy re-
quirements [59,60]. However, if the description was made by fat
weight and the metabolized energy per weight of food was
available, energy from fat was calculated by assuming (as
deﬁned by FAO) that 1 g of fat¼9 kcal¼37 kJ (FAO, 2013).
) Some authors describe the fat content of their diet, including
individual fatty acid type. However, most only describe the
main source of fat, i.e. lard, vegetable oil, or ﬁsh. In addition to
the seasonality and origin of the fat, the proportionality trend of
fat classes could be deﬁned using the Fat and Oils Handbook [8].
In Table 2, we summarize the percentage of energy from fat of
collected studies and in Fig. 3, the main source described by the
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Fig. 2. Rodent age and treatment duration distribution. A) Cumulative distribution of initial and maximum age and treatment duration; AveragesþSEM are depicted in B.
Results were not signiﬁcantly different.
Table 2
Dietary energy from fat (percentage).
HFD (n¼32) Control (n¼33) Fold change (n¼32) vs. Control
Minimum 40.0 8.0 2.0
Median 51.8 11.4 4.5
Maximum 71.0 35.0 6.8
Mean 52.679.9 13.577.1 4.371.2
P.A. Kakimoto, A.J. Kowaltowski / Redox Biology 8 (2016) 216–225218authors or manufacturer. Most of the papers uncovered used
manufactured puriﬁed diet that usually follows some of the re-
quirements of AIN-93M deﬁned by the American Institute of Nu-
trition in 1993 in order to obtain a global standard for rodent
nutrition [58]. Ingredients can be added or removed from the re-
commended diet, but are always maintained in control animal
groups [59]. In addition, puriﬁed HFD comparison against chow
diet is not advisable: Regular chow diets are made from naturalFat Source
Butter
Lard
Fish Oil
Coconut Oil
Corn Oil
Olive Oil
Safflower oil
Soybean oil
Mixed sources
Fig. 3. Frequency distribution ofingredients and this can cause variations in contents due to sea-
sonality, origin or differences in metabolic responses due to phy-
toestrogen contents [11,43,5,59]. As a result, changes other than
those attributed to the high fat content may occur in the animals.
Lieber et al. [45], proposed a NAFLD model using a puriﬁed li-
quid diet containing 71% energy from fat (mainly corn oil, with a
prevalence of omega 6 fatty acids) versus an isocaloric control diet
containing the same ingredients, but 35% energy from fat. Buettner
et al. [11] suggest that more than 30% energy from fat might al-
ready be a HFD and believe over 60% would present questionable
results comparative to human diets, an observation that the au-
thors of this review support. They fed Wistar rats for 3 weeks and
observed increased lipid accumulation in the livers from both
groups. The called “Liber-DeCarli” was diet used in two other pa-
pers analyzed [17,46]. Mantena et al. [48] describe the develop-
ment of steatosis that resembles human NASH [70] with this diet,
including macro and microvesicular inclusions, Mallory bodies andFat Type
MUFA > Omega 6 > SFA > Omega 3
MUFA > SFA > Omega 6 >Omega 3
Omega 6 > MUFA > SFA > Omega 3
PUFA > MUFA > SFA
SFA > MUFA > Omega 6 > Omega 3
SFA > PUFA > MUFA
UFA > SFA
fat sources and type of diet.
P.A. Kakimoto, A.J. Kowaltowski / Redox Biology 8 (2016) 216–225 219hepatocyte ballooning. However, the protocol is criticized due lack
of reproducibility [1,50].
Enos et al. [20] described an interesting experimental design to
evaluate the impact of differential fatty acid composition on cel-
lular processes known to be obesity-related. Brieﬂy, they used
three puriﬁed HFDs with different concentrations of SFAs (6%, 12%
and 24%) that are MUFA4omega 64SFA4omega 3,
MUFA4SFA4omega 64omega 3 and SFA4MUFA4omega
64omega 3 relations, respectively. In addition, they used two
puriﬁed control diets in order to pair omega 3/omega 6 ratios with
the HFDs. In Enos et al. [21] they describe that after 16 weeks the
12% SFA group gained more body and adipose tissue weight than
controls and HFD groups, and presented the highest plasma in-
sulin levels despite unchanged glucose plasmatic levels. This
suggests more accentuated insulin resistance generated by
MUFA4SFA4omega 64omega 3 composition, a dietary inter-
vention more closely related to the standard Western diet. In their
2014 paper, they show that only 6 and 12% HFDs induce steatosis
and that only the 12% group had increased 4-HNE content in the
liver, as well as JNK pathway activation and ER stress, suggesting a
speciﬁc fatty acid sensitivity in the liver.
Even though HFDs are often used to promote obesity in ro-
dents, some authors did not ﬁnd statistical differences in bodyTable 3
Changes in body weight after HFD.
Authors Strain Sex Age (w) Duration (w) H
f
Decreased body weight (vs. indicated control group)
Buettner et al. [10] Wistar M 6 12 4
Increased body weight (vs. indicated control group)
Rats
Buettner et al. [10] Wistar M 6 12 4
Nadal-Casellas et al. [51] Wistar Both 10 26 5
Cipaite et al. [16] Wistar M 14 2.5 or 25 4
Flamment et al. [24] Sprague Dawley M 10 2, 4 or 8 –
Herlein et al. [33] Sprague Dawley M 7.5 16 6
Lionetti et al. [47] Wistar M 8 6 4
Mice
Gallou-Kabani et al. [28] C57BL/6J or A/J Both 4 20 6
Chan et al. [15] C57BL/6J F 8 10 4
Cardoso et al. [13] Swiss F 6 8 or 40 –
Poussin et al. [56] C57BL/6J M 5 30 days 5
Satapati et al. [63] C57BL/6J M 5 8, 16 or 32 6
Kahle et al. [38] C3HeB/FeJ, 129P2/
OlaHsd
M 14 1, 2 or 3 5
Kahle et al. [38] C57BL/6NTac, C57BL/
6J
M 14 2 or 3 5
Yuzefovych et al. [75] C57BL/6J M 6 16 6
Nesteruk et al. [52] C57BL/6J M 6 10 or 42 6
Franko et al. [27] C57BL/6N M 4 20 6
Enos et al. [20] C57BL/6 M 4 16 4
Kahle et al. [39] C3HeB/FeJ M 14 1, 2 or 3 5
Non-signiﬁcant changes (vs. indicated control group)
Rats
Lieber et al. [45] Sprague Dawley M – 3 7
Cipaite et al. [17] Wistar M – 7 5
Vial et al. [72] Wistar M 16 8 –
Aoun et al. [3] Wistar M 6 12 5
Aoun et al. [4] Wistar M 6 12 5
Mice
Chan et al. [15] C57BL/6J F 8 2 or 4 4
Eccleston et al. [19] C57BL/6J M 8 16 7
Poussin et al. [56] A/J M 5 2, 10 or 30 days 5
Poussin et al. [56] C57BL/6J M 5 2 or 10 days 5
Kahle et al. [38] C57BL/6J and C57BL/
6NTac
M 14 1 5
Cardoso et al. [14] Swiss F 6 1 –
Ho et al. [35] BALB/c M 8 8, 24 or 32 6
&¼calculated energy from fat based on information provided by the authors. 1 g fat¼9weight when compared to standard laboratory animals (Table 3).
Rodents, unlike humans, are considered obese when increases in
body weight or body fat content are seen, and are not usually
evaluated by measurements such as body mass indexes [32]. The
same lack of a homogeneous metabolic change is observed when
measuring plasma glucose and insulin levels (Table 4). This lack of
a universal body weight and metabolic change may be a reﬂection
of the fact that “control” laboratory animals are sedentary and
obese due to access to ad libitum diets [49], or due to differences in
dietary protocols. Despite this lack of a homogeneous response in
weight and insulin levels, the development of HFD-induced stea-
tosis is consistently observed as changes in histology or by in-
creased lipid content in the liver. Some other trends can be seen,
such as the more favorable metabolic outcome when animals are
fed with ﬁsh oil [10,3,47].4. Mitochondrial (Dys)function
Mitochondrial function is evaluated by assessing its ability to
produce ATP under physiological conditions and under stress
[34,9]. In isolated mitochondria, the best and simplest way to as-
sess function (and, thus, dysfunction) is by measuring respiratoryFD (% energy from
at)
Control (% energy
from fat)
Main fat source
2 11 Fish
2 11 Lard, coconut or olive oils
4,5 8 Cafeteria diet
5,7 9.2 Lard
8.75 & Lard
0 13 Lard
0 10.6 Lard or ﬁsh
0 10 Lard
0 12 Butter
14.3 & Soybean oil
8 12.70 & Coconut oil
0 10 Lard
8 13 Safﬂower oil
8 13 Safﬂower oil
0 10 Lard
0 10 Lard
0 & 13 & Lard
0 12.5 Lard, coconut, corn, soybean and
olive oil
8 13 Safﬂower oil
1 35 Corn oil
0.4 16.4 –
– Lard
1.8 & 11.4 & Lard or Fish
1.8 & 11.4 & Lard
0 12 Butter
1 35 Corn oil
8 12.70 & Coconut oil
8 12.70 & Coconut oil
8 13 Safﬂower oil
14.3 & Soybean oil
0 10 Lard
kcal¼37 kJ [22].
Table 4
Changes in plasma glucose and insulin levels after HFD.
Authors Strain Sex Age (w) Duration (w) HFD (% energy
from fat)
Control (% energy
from fat)
Main fat source Glucose Insulin
Rats
Lieber et al. [45] Sprague
Dawley
M – 3 71 35 Corn oil – Increased
Buettner et al. [10] Wistar M 6 12 42 11 Fish and coconut oil ns ns
Buettner et al. [10] Wistar M 6 12 42 11 Lard ns Increased
Buettner et al. [10] Wistar M 6 12 42 11 Olive oil Increased ns
Cipaite et al. [17] Wistar M – 7 50.4 16.4 Increased –
Rafaella et al. [57] Wistar M 12 7 50 10.6 Butter ns
Cipaite et al. [16] Wistar M 14 2.5 and 25 45.7 9.2 Lard ns Increased
Flamment et al. [24] Sprague
Dawley
M 10 2, 4 and 8 8.75 & Lard Increased Increased
Aoun et al. [3] Wistar M 6 12 51.8 & 11.4 & Fish or lard ns Increased
Herlein et al. [33] Sprague
Dawley
M 7,5 16 60 13 Lard ns ns
Lionetti et al. [47] Wistar M 8 6 40 10.6 Lard Increased Increased
Lionetti et al. [47] Wistar M 8 6 40 10.6 Fish Increased ns
Mice
Gallou-Kabani et
al. [28]
C57BL/6J M 4 20 60 10 Lard Increased Increased
Gallou-Kabani et
al. [28]
A/J M 4 20 60 10 Lard ns Increased
Gallou-Kabani et
al. [28]
C57BL/6J F 4 20 60 10 Lard Increased –
Gallou-Kabani et
al. [28]
A/J F 4 20 60 10 Lard ns –
Chan et al. [15] C57BL/6J F 8 2 and 4 40 12 Butter ns –
Chan et al. [15] C57BL/6J F 8 10 40 12 Butter Increased –
Chan et al. [15] C57BL/6J F 8 4 40 12 Butter ns –
Cardoso et al. [13] Swiss F 6 8 and 40 14.3 & Soybean oil ns –
Eccleston et al. [19] C57BL/6 M 8 16 71 35 Corn oil Increased ns
Poussin et al. [56] C57BL/6J M 5 2 d 58 12.70 & Coconut oil Decreased ns
Poussin et al. [56] C57BL/6J M 5 10 d 58 12.70 & Coconut oil ns ns
Poussin et al. [56] C57BL/6J M 5 30 d 58 12.70 & Coconut oil Decreased ns
Poussin et al. [56] A/J M 5 2 d 58 12.70 & Coconut oil ns ns
Poussin et al. [56] A/J M 5 10 d 58 12.70 & Coconut oil Increased ns
Poussin et al. [56] A/J M 5 30 d 58 12.70 & Coconut oil ns ns
Satapati et al. [63] C57BL/6 M 5 8, 16 and 32 60 10 Lard Increased Increased
Kahle et al. [38] C3HeB/FeJ M 14 1 and 2 58 13 Safﬂower oil ns ns
Kahle et al. [38] C3HeB/FeJ M 14 3 58 13 Safﬂower oil ns Increased
Kahle et al. [38] C57BL/6NTac M 14 1 and 2 58 13 Safﬂower oil ns ns
Kahle et al. [38] C57BL/6NTac M 14 3 58 13 Safﬂower oil Increased Increased
Kahle et al. [38] C57BL/6J M 14 1, 2 and 3 58 13 Safﬂower oil ns ns
Kahle et al. [38] 129P2/OlaHsd M 14 1 and 2 58 13 Safﬂower oil ns ns
Kahle et al. [38] 129P2/OlaHsd M 14 3 58 13 Safﬂower oil ns Increased
Cardoso et al. [14] Swiss F 6 1 14.3 & Soybean oil ns –
Ho et al. [35] BALB/c M 8 8, 24 and 32 60 10 Lard ns Increased
Yuzefovych et al. [75] C57BL/6J M 6 16 60 10 Lard Increased Increased
Franko et al. [27] C57BL/6 M 4 20 60 & 13 & Lard Increased Increased
Enos et al. [20] C57BL/6 M 4 16 40 12.5 Lard, coconut, corn, soybean
and olive oil
Increased Increased
Kahle et al. [39] C3HeB/FeJ M 14 1 and 2 58 13 Safﬂower oil ns ns
Kahle et al. [39] C3HeB/FeJ M 14 3 58 13 Safﬂower oil ns Increased
&¼calculated energy from fat based on information provided by the authors. 1 g fat¼9 kcal¼37 kJ [22].
ns¼authors did not ﬁnd statistically signiﬁcant differences.
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challenged by the addition of substrates and pharmacological in-
hibitors in an isolated chamber containing an oxygen electrode, in
order to modulate and record oxygen consumption rates. State
3 respiration is measured in the presence of ample substrates and
ADP, and is related to its phosphorylation. State 4 occurs when ATP
synthesis is inhibited by high ATP/ADP ratios or the inhibition of
ATP synthesis. The respiratory control ratio (RCR) is calculated
determining the state 3/state 4 ratio and functionally healthy
mitochondria should have high RCRs [9].
Bioenergetic results of HFD varied highly with the highly
variable dietary interventions (Table 5). Decreased or unchanged
state 3 respiratory rates are often observed when using malate,
glutamate and/or pyruvate, complex I related substrates, orsuccinate, a complex II substrate [67]. Studies using palmitoyl-
carnitine, a lipid substrate [42,73] had inconsistent results: some
authors found an increase [14,17,47,63] and others, a decrease
[24,56,57,72] in respiratory rates. There is no evident trend to
explain this discrepancy considering the fat source, treatment
duration, rodent species or strain, or initial age.
In agreement with the observed increase in respiration seen by
some authors in samples energized with palmitoyl-carnitine, β-
oxidation activities of long chain fatty acids were found to be in-
creased after a 1 week HFD [14]. This increased activity was ac-
companied by increased expression of β-oxidation enzymes. In-
creased palmitate oxidation was also observed by Satapati et al.
[63] after longer HFD treatment. Indeed, increased carnitine pal-
mitate transferase 1a (CPT1a) mRNA, protein expression and/or
Table 5
Oxygen consumption in isolated liver mitochondria.
Authors Strain Sex Age (w) Duration (w) HFD (% energy
from fat)
Control (% en-
ergy from fat)
Main fat
source
Main observations (vs. indicated control
group)
Rats
Cipaite et al. [17] Wistar M – 7 50.4 16.4 – Succinateþrotenone:
ns state 3
Rafaella et al. [57] Wistar M 12 7 50 10.6 Butter Glutamateþmalate:
Decreased states 3 and 4; ns RCR
Palmitoyl-CoAþcarnitineþmalate
Decreased states 3 and 4; ns RCR
Succinateþrotenone:
Decreased states 3 and 4; ns RCR
Nadal-Casellas
et al. [51]
Wistar M 10 26 54.5 8 Cafeteria diet Succinate:
Decreased states 3 and 4; ns RCR
Vial et al. [72] Wistar M 16 8 – – Lard Succinateþglutamateþmalate:
Decreased state 3, ns state 4
Palmitoyl-carnitine:
Decreased state 3,
ns state 4
Glutamateþmalate:
ns state 3,
increased state 4
Cipaite et al. [16] Wistar M 14 2.5 and 25 45.7 9.2 Lard Pyruvateþmalate:
Decreased states 3 and uncoupled,
ns state 4 RCR decreased by diet and age.
Palmitoyl-carnitineþmalate:
Increased states 3 and uncoupled;
ns state 4 –the three parameters were decreased
by age
ns RCR
Aoun et al. [4] Wistar M 6 12 51.8 & 11.4 & Fish or Lard Malateþglutamateþsuccinate:
ns states 3, 4 and uncoupled.
Increased RCR in three HFDs groups
Flamment et al.
[24]
Sprague
Dawley
M 10 2, 4 or 8 w 8.75 & Lard Pyruvateþmalate
ns states 3 and 4
ns RCR
Succinateþrotenone
ns States 3 and 4
ns RCR
Palmitoyl-carnitineþmalate
Decreased at 8w
RCR decreased at 8w
Herlein et al. [33] Sprague
Dawley
M 7,5 16 60 13 Lard Succinate:
ns State 4
Lionetti et al. [47] Wistar M 8 6 40 10.6 Lard Pyruvateþmalate:
ns States 3 and 4
ns RCR
Succinateþrotenone:
Decreased states 3, 4 and uncoupled
ns RCR.
Palmitoyl-CoAþmalate:
Increased states 3 and 4.
ns RCR.
Decreased proton leak under palmitate.
Lionetti et al. [47] Wistar M 8 6 40 10.6 Fish Pyruvateþmalate:
ns States 3 and 4
ns RCR
Succinateþrotenone:
ns states 3, 4 and uncoupled.
ns RCR.
Palmitoyl-CoAþmalate:
Increased states 3 (higher than in lard) and 4.
ns RCR.
Increased proton leak under palmitate.
Mice
Mantena et al.
[48]
C57BL/6J M 8 8 and 16 71 35 Corn oil Glutamateþmalate:
Decreased states 3 and RCR at 16w.
ns state 4
Succinateþrotenone:
Decreased states 3 and uncoupled.
ns state 4
Decreased RCR at 8 and 16w
Cardoso et al. [13] Swiss F 6 8 and 40 – 14.3 & Soybean oil Succinate:
ns state 3, 4 and RCR.
Poussin et al. [56] A/J M 5 2, 10 or 30
days
58 12.70 & Coconut oil Succinateþrotenone:
Increased states 2, 3 and 4.
Decreased RCR.
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Table 5 (continued )
Authors Strain Sex Age (w) Duration (w) HFD (% energy
from fat)
Control (% en-
ergy from fat)
Main fat
source
Main observations (vs. indicated control
group)
Palmitoyl-carnitine:
Decreased states 2 and 3.
Decreased RCR.
Poussin et al. [56] C57BL/6 J M 5 2, 10 or 30
days
58 12.70 & Coconut oil SuccinateþRotenone:
Decreased state 3.
Palmitoyl-carnitine:
Decreased state 2.
Satapati et al. [63] C57BL/6NCrl M 5 8, 16 or 32 60 10 Lard Glutamateþmalate:
Increased states 2 and 4 at 32w.
ns state 3 and RCR.
Succinateþrotenone:
Increased state 4 at 32w.
ns state 2, 3 and RCR.
Palmitoyl-carnitine:
Increased state 2, 3 and 4 at 32w.
Decreased RCR.
Cardoso et al. [14] Swiss F 6 1 – 14.3 & Soybean oil Succinate:
ns states 2, 3, 4, uncoupled and RCR.
Palmitoyl-carnitine:
ns states 2, 4 and RCR.
Increased states 3 and uncoupled.
Franko et al. [27] C57BL/6N M 4 20 60 & 13 & Lard Pyruvateþmalate:
ns states 3 and 4.
Malateþglutamate
ns state 3
Succinate:
ns state 3
Glycerol-3-phosphate:
Increased state 3.
Decreased proton leak under succinate.
&¼calculated energy from fat from the information provided by the authors. 1 g fat¼9 kcal¼37 kJ [22].
ns¼authors did not ﬁnd statistically signiﬁcant differences.
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[24] suggest that an inversion of fatty acid metabolism adaptation
occurs because they see an increased content of seric β-hydro-
xybutyrate, a β-oxidation biomarker, at 4 weeks on a HFD. This is
abrogated at 8 weeks following a decrease in state 3 fatty acid-
related respiration. They do not ﬁnd any changes in CPT1a mRNA
expression at any time point. Aoun et al. [4] saw a decrease in β-
hydroxyacyl-CoA dehydrogenase (the last step in mitochondrial β-
oxidation) in three HFD (basal, lard and ﬁsh). Vial et al. [72] hy-
pothesized that lower fatty acid oxidation (despite higher capa-
city) could be related to inhibited oxidative phosphorylation at
complex IV and a lower cellular redox state, with increased oxi-
dant production. It should be noted that most of these contra-
dictory results were obtained in HFD containing lard as the main
source of fat (Table 3).
Lionetti et al. [47] compared mitochondrial function and dy-
namics in Wistar rats fed with a lard or ﬁsh-based diet (40% en-
ergy from fat, ﬁsh fat from cod liver) for six weeks. That evaluation
was similar to the one published by Aoun et al. [4] using a different
experimental design (12 weeks treatment, calculated 51.8% energy
from fat; lard or ﬁsh fat from tuna and sardine oils). They observed
that fat quantity, not quality, had a more prominent increased
effect on mitochondrial membrane ﬂuidity and membrane po-
tentials, but not oxygen consumption. β-oxidation, however, was
reduced in all three diets, although the effect was more pro-
nounced in ﬁsh and basal (lardþmixed vegetable oils) diets than
when using lard. Additionally, Aoun's ﬁsh HFD mice did not show
changes in body weight, plasma glucose or insulin, despite stea-
totic livers [3]. Lionetti et al. [47], in contrast, observed a higher
state 3 (palmitoyl-CoA energized) oxygen consumption on lard,
but even higher on ﬁsh-based diets. Probably as a reﬂex of diet
composition, a decreased proton leak was seen in the lard group,
while it was increased in ﬁsh. In respect to the diet, both Aoun andLionetti control diets were low fat puriﬁed and, thus, precise in all
ingredients, avoiding chow vs. high fat misconceptions [32,43].
The main probable differences are the ﬁsh species and the lard
content in the “ﬁsh” Aoun diet.
Interestingly, Lionetti et al. [47] also observed that the lard group
had shorter mitochondria, predominantly tubular, while the ﬁsh group
mitochondria were more elongated, in equivalent proportions of
tubular and round shapes. This suggests dominant ﬁssion and fusion
processes, respectively. Adaptations in mitochondrial shape, mor-
phology and dynamics have been discussed as sensors for the control
of energy demand and supply; more fragmented mitochondria have
been associated with decreased function (reviewed by [46]). Other
papers discussed mitochondrial dynamics brieﬂy; Guo et al. [31] also
observed more fragmented mitochondria in HFD groups after 30
weeks treatment (60% energy from fat, containing mainly lard).
However, Raffaella et al. [57] found increased mitochondrial volume
density and area, despite the same number of organelles after 7 weeks
(50% energy from fat, containing mainly butter).
Gallou-Kabani et al. [28] fed HFDs to a large cohort of A/J (obesity
resistant) and C57BL/6J (obesity prone) mice for 20 weeks (60% en-
ergy from fat, mainly lard) and did not ﬁnd differences in ﬁnal body
weights. All mice were glucose intolerant and insulin resistant,
however, these ﬁndings were more pronounced in A/J males. The
authors suggest both C57BL/6J and A/J are good models to evaluate
disparities in the time course of glucose homeostasis impairment.
Furthermore, Poussin et al. [56] compared the liver adaptive process
of A/J mice versus C57BL/6J under HFD. They observed that after 10
days feeding with HFD containing 58% energy from fat, mainly co-
conut oil, liver mitochondria energized by succinate or palmitoyl-
carnitine had increased oxygen consumption (higher state 3 and 4)
compared to normal chow in A/J and C57BL/6 mice, although the ATP
production rate was the same. A/J mice also had a transient upre-
gulation of mitochondrial complexes at the second and tenth days.
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P.A. Kakimoto, A.J. Kowaltowski / Redox Biology 8 (2016) 216–225 223The authors hypothesized that these differences could be related to
increased peroxisomal β-oxidation and uncoupled mitochondria.
This would be one of the metabolic adaptation tools to protect A/J
mice from developing obesity and related metabolic diseases. Despite
this, 30 days on HFD did not caused glucose or insulin changes in A/J
or C57BL6/J mice, although only obesity-prone mice had increased
body weight (Tables 4 and 5).
Chan et al. [15] showed that during the ﬁrst 4 weeks of HFD
feeding (40% energy from fat, mainly butter), genes regulating lipo-
genesis and cholesterol metabolism are downregulated, while the
ones related to fatty acid oxidationwere upregulated. After 10 weeks,
however, the trend was the opposite. The authors suggest that this
reﬂects an attempt to maintain energy homeostasis, which failed
after 4 weeks. In the same adaptation hypothesis line, Franko et al.
[27] did not observe distinctive mitochondrial differences in HFD
(60% calculated energy from fat, mainly lard) groups after 20 weeks
(unchanged protein and mRNA levels of respiratory complexes, no
changes in oxidative phosphorylation), despite the development of
steatosis and blunted glucose homeostasis [26]. They suggest that
steatosis and insulin resistance do not cause mitochondrial dys-
function in liver; instead, they elicit an adaptive response with in-
creased ETC performance and coupling in order to handle the nu-
trient overload and insulin inability to suppress gluconeogenesis.D
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.5. Oxidative imbalance
It is widely accepted that mitochondrial oxidative imbalance
contributes toward the development and progression of NAFLD
and related metabolic diseases ([61,6]). Indeed, most HFD models
lead to increased mitochondrial hydrogen peroxide production
(Table 6), higher incidence of oxidative damage markers (for ex-
ample increased lipid oxidation, carbonylated proteins, 3-ni-
trotyrosine levels, and reduced aconitase activity), and decreased
antioxidant defenses (Table 7), suggesting oxidative imbalance
occurs in HFD animals. Cardoso et al. [14] described a diet-sensi-
tive source of hydrogen peroxide production related to long chain
fatty acid metabolism: the ﬁrst dehydrogenation of pamitoyl-CoA
catalyzed by very long chain acyl CoA dehydrogenase (VLCAD) was
identiﬁed as an important electron leak step in mitochondrial β-
oxidation. In addition, our in vitro assays uncovered a residual
oxidase activity for VLCAD, generating H2O2 [40].Ta
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s.6. Conclusions
A broad look at publications studying bioenergetic and redox
effects of HFD clearly shows that immense variability exists re-
garding how these dietary interventions are designed. Despite this
variability, some ﬁndings are highly reproducible:
 HFDs induce steatosis, even when no changes in insulin sig-
naling or weight are found.
 HFDs activate β-oxidation, as measured both by expression le-
vels and activity of enzymes in this pathway.
 HFDs promote oxidative imbalance, as evidenced both by the
measurement of H2O2 production and changes in biomarkers.
On the other hand, many other comparisons are confounded by
the variability in dietary interventions. In this sense, we would like
to suggest points to be considered when designing HFD studies in
order to increase future reproducibility in this area:
 Avoid the use of unknown diets for the control groups. Pair the
composition of the HFD and control diet so that the signiﬁcant
change in the diet is the fat content itself.
Table 7
Redox evaluation.
Authors Strain Sex Age (w) Duration (w) HFD (% en-
ergy from fat)
Control (% en-
ergy from fat)
Main fat source Findings (vs. indicated control group)
Rats
Rafaella et al. [57] Wistar M 12 7 50 10.6 Butter ns SOD activity;
Decreased aconitase activity;
Increased TBARS
Nadal-Casellas et
al. [51]
Wistar Both 10 26 54.5 8 Cafeteria diet Decreased GPx, MnSOD expression, and
GSH content;
ns TBARS and Carbonylated protein
Cipaite et al. [16] Wistar M 14 2.5 45.7 9.2 Lard ns TBARS and Carbonylated protein
Cipaite et al. [16] Wistar M 14 25 45.7 9.2 Lard Increased TBARS and Carbonylated
protein
Herlein et al. [33] Sprague
Dawley
M 7,5 16 60 13 Lard ns GPx and MnSOD expression
Lionetti et al. [47] Wistar M 8 6 40 10.6 Lard Decreased aconitase activity; Increased
3-NT
Lionetti et al. [47] Wistar M 8 6 40 10.6 Fish ns aconitase activity and 3-NT
Mice
Mantena et al. [48] C57BL/6J M 8 16 71 35 Corn oil Increased 3-NT
Satapati et al. [63] C57BL/6NCrl M 5 8 60 10 Lard ns SOD activity and TBARS
Satapati et al. [63] C57BL/6NCrl M 5 16 60 10 Lard ns SOD activity and TBARS
Satapati et al. [63] C57BL/6NCrl M 5 32 60 10 Lard Increased SOD activity and TBARS
Cardoso et al. [14] Swiss F 6 1 – 14.3 & Soybean oil Increased carbonylated protein
Yuzefovych et
al. [75]
C57BL/6J M 6 16 60 10 Lard Decreased MnSOD content, GSH/GSSG
ratio and SOD expression; Increased
carbonylated protein
Franko et al. [27] C57BL/6N M 4 20 60 & 13 & Lard ns MnSOD content
ns Aconitase activity
Enos et al. [21] C57BL/6 M 4 16 40 12.5 Lard, and coconut,
corn, soybean and ol-
ive oils
Increased 4-HNE content in 12% SFA
group
&¼calculated energy from fat from the information provided by the authors. 1 g fat¼9 kcal¼37 kJ [22].
ns¼authors did not ﬁnd statistically signiﬁcant differences.
P.A. Kakimoto, A.J. Kowaltowski / Redox Biology 8 (2016) 216–225224 Specify the full dietary content for both control and HFD groups
in publications. Specify the source and type of fat added.
 Be aware of the fact that “control” ad libitum and sedentary
animal group may present signiﬁcant metabolic disorders and
may not be a good model for a healthy human [49].
 Care must be taken in the literature regarding different treatment
times, since short and long term treatment deﬁnitions often vary
signiﬁcantly among groups. We propose that short term treatments
comprise those of a week or less on the HFD. Treatment time and
age when the diet was introduced should be speciﬁed in the text.
 Choose the rodent species, strain (and in some cases, substrain),
sex and initial age carefully based on prior studies.Acknowledgments
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